Insider Holders & Insider Ownership - Catalent Inc. (CTLT)

List of insiders holdings for Catalent Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
Zippelius Peter
Director
2022-10-31 17:46:2411,979
4,330,462
4,342,441Form 4
Chiminski John R
Executive Chair
2022-08-26 20:16:30229,888
0
229,888Form 4
Maselli Alessandro
President & CEO
2024-07-30 16:53:51177,521
0
177,521Form 4
GREISCH JOHN J
Executive Chair
2024-07-30 17:36:1879,932
34,000
113,932Form 4
Gennadios Aristippos
Group Pres. Pharma & Consumer
2024-08-05 12:33:35113,724
0
113,724Form 4
WALSH MATTHEW M
EVP & Chief Financial Officer
2017-08-28 12:29:43103,703
0
103,703Form 4
Joseph Wetteny
SVP & Chief Financial Officer
2021-02-18 09:56:2079,227
0
79,227Form 4
Johnson Sharon
See Remarks
2017-04-27 11:02:1977,645
0
77,645Form 4
Masanovich Matti
SVP, Chief Financial Officer
2024-07-30 16:58:5676,475
0
76,475Form 4
Fasman Steven L
EVP & Chief Admin Officer
2023-12-12 19:11:2375,423
0
75,423Form 4/A
Leonard Stephen
See Remarks
2016-07-28 19:21:1273,140
0
73,140Form 4
MOREL DONALD E JR
Director
2024-11-01 17:07:5570,118
0
70,118Form 4
Arnold Jonathan
SVP, CCO & Div. Head BioP Del.
2023-12-12 18:58:2057,573
0
57,573Form 4/A
Kurt Nielsen
See Remarks
2015-02-19 19:28:3557,156
0
57,156Form 4/A
Dolan Christine
SVP - Product Development
2017-08-31 10:41:2653,736
0
53,736Form 4
STAHL JACK L
Director
2024-11-01 16:48:1947,984
0
47,984Form 4
CLASSON ROLF A
Director
2024-11-01 16:54:2347,984
0
47,984Form 4
Miyamoto Lance
SVP, Human Resources
2019-03-11 19:31:1446,799
0
46,799Form 4
Downie William
SVP, Global Sales & Marketing
2019-02-20 15:48:5246,662
0
46,662Form 4
BUZY PETER L
President, Gene Therapy
2020-04-13 12:12:2645,950
0
45,950Form 4
Littlejohns Barry
President, Biologics & SDD
2019-08-26 15:49:3245,882
0
45,882Form 4
Gunther Scott
SVP, Quality & Reg. Affairs
2024-08-05 12:51:0539,635
0
39,635Form 4
Evoli Lisa
SVP, Chief HR Officer
2024-08-05 12:39:5739,366
0
39,366Form 4
LUCIER GREGORY T
Director
2024-11-01 16:58:5436,914
0
36,914Form 4
McErlane David
Group President, Biologics
2024-09-27 12:01:2336,304
0
36,304Form 4
CARROLL J MARTIN
Director
2024-11-01 17:04:2232,734
0
32,734Form 4
Pravda Ricardo
Chief Transformation Officer
2023-12-12 19:21:4030,982
0
30,982Form 4/A
Hopson Ricky
Pres. BioProduct Delivery, CoS
2024-08-05 12:55:5029,974
0
29,974Form 4
Balachandran Madhavan
Director
2023-10-31 17:07:4027,441
0
27,441Form 4
Grippo Michael J
SVP, Strategy & Corp. Dev.
2023-12-12 19:05:2525,229
0
25,229Form 4/A
Flynn Karen
Director
2023-10-31 17:00:5424,339
0
24,339Form 4
Ferraro Joseph Anthony
SVP, General Counsel, CCO
2024-10-21 11:30:3123,967
0
23,967Form 4
Crane Rosemary A
Director
2023-10-31 17:02:0823,873
0
23,873Form 4
QUELLA JAMES
Director
2017-08-28 11:31:4820,641
0
20,641Form 4
Castellano Thomas P
SVP, Chief Financial Officer
2022-08-26 20:16:0320,099
0
20,099Form 4
Kreuzburg Christa
Director
2024-01-29 16:09:0518,283
0
18,283Form 4
Barber Michael J
Director
2024-11-01 17:11:1418,052
0
18,052Form 4
Schmidt Kay A
SVP, Enterprise Functions
2022-08-26 20:23:5917,388
0
17,388Form 4
BOOTH MELVIN D
Director
2016-08-26 14:56:5016,665
0
16,665Form 4
Roehrhoff Uwe
Director
2017-11-22 16:25:2816,489
0
16,489Form 4
Houlton Scott
See Remarks
2015-09-04 17:39:2716,380
0
16,380Form 4
Zayas Ricardo
SVP, Operations, Biologics NA
2023-08-03 17:17:2316,101
0
16,101Form 4
Boerman Manja
Pres. BioModalities Division
2023-05-03 19:00:3714,414
0
14,414Form 4
Ryan Michelle R
Director
2024-11-01 17:20:3113,635
0
13,635Form 4
Hatzfeld Michael
Chief Accounting Officer
2024-07-30 17:26:5413,532
0
13,532Form 4
DAMELIO FRANK A
Director
2024-11-01 17:14:2112,635
0
12,635Form 4
Okey Stephanie
Director
2024-11-01 17:17:2912,635
0
12,635Form 4
Barg Steven
Director
2024-11-01 17:23:5712,374
0
12,374Form 4
HEGWOOD PAUL W JR
President, CSS
2019-08-26 15:48:2611,848
0
11,848Form 4
Lickfold Charles
SVP, CIO
2023-12-12 19:19:5411,719
0
11,719Form 4/A
Hunt Patricia
Pres. Consumer Health Div
2023-12-12 19:17:5111,501
0
11,501Form 4/A
Santiago Karen Murphy
VP & Chief Accounting Officer
2023-08-03 17:21:219,979
0
9,979Form 4
Carletti Lorenzo
SVP Global Ops Ph & Cons Hlth
2023-12-12 19:09:149,178
0
9,178Form 4/A
Hawkeswood Thomas W
Pres. Pharma Prod Delivery Div
2023-12-12 19:16:027,827
0
7,827Form 4/A
Riley Michael A.
Pres. Bio Product Delivery Div
2022-08-30 14:38:016,592
0
6,592Form 4
Gargiulo Mario
SVP, Ops, Biologics Europe
2023-05-03 18:58:005,676
0
5,676Form 4
Whitlow Ricci S
President, CSS
2022-01-24 16:42:462,923
0
2,923Form 4
Blackstone Management Associates V L.L.C.
Blackstone Healthcare Partners L.L.C.
BLACKSTONE CAPITAL PARTNERS V L P
BMA V L.L.C.
Blackstone Holdings III L.P.
Blackstone Holdings III GP L.P.
Blackstone Holdings III GP Management L.L.C.
Blackstone Group L.P.
Blackstone Group Management L.L.C.
SCHWARZMAN STEPHEN A
10% Owner
2017-02-14 14:25:560
0
0Form 13G
Chu Chinh
Director
2014-07-31 20:29:590
0
0Form 3
McEvoy Bruce
Director
2014-07-31 20:19:300
0
0Form 3